New York, NY, United States of America

Stephen E Karpiak


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1984-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Stephen E. Karpiak: A Focus on Analgesia

Introduction

Stephen E. Karpiak, an innovative inventor based in New York, NY, is recognized for his contributions to the field of analgesics. With two patents to his name, Karpiak's work centers around the development of derivatives of 5-hydroxytryptophan, which have significant implications for pain management.

Latest Patents

Karpiak's latest patents include N-acylated 5-hydroxytryptophan amide derivatives. These derivatives are designed to provide analgesia effects and are characterized by the formulae that include variations of R, selected from a variety of aliphatic and aromatic alkyl groups. Specifically, these groups range from C2 to C16 alkyl, C3 to C8 cycloalkyl, as well as C2 to C16 alkenyl and alkynyl. Additionally, he introduced N-hexanoyl to n-heptadecanoyl 5-hydroxy derivatives, also structured to deliver analgesia through similar chemical configurations.

Career Highlights

Throughout his career, Stephen E. Karpiak has made significant strides in the research field. He has worked with notable organizations, including the Research Foundation for Mental Hygiene, Inc. and Yeda Research and Development Company. His research has played an essential role in the advancement of medications aimed at pain relief.

Collaborations

Karpiak's innovations have been enriched through collaborations with esteemed colleagues such as Hadassah Tamir and Meir Wilchek. Their collective expertise has contributed to the success of the patents developed by Karpiak and further underscores the importance of teamwork in scientific research.

Conclusion

In summary, Stephen E. Karpiak's advancements in developing analgesia-effective compositions illustrate the potential for innovation within the pharmaceutical industry. His patents not only highlight the efficacy of 5-hydroxytryptophan derivatives but also reflect a commitment to improving pain management solutions. As research continues to evolve, Karpiak's contributions will undoubtedly leave a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…